Identification of Bacteroides Fragilis Colonization during Host Mutualism
Identification of Bacteroides Fragilis Colonization during Host Mutualism
批准号:
7790135
负责人:
Sarkis K Mazmanian
金额:
$28.35万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-04-15 至 2012-01-31
关键词:
AffectAnimalsAreaBacteriaBacteroidesBacteroides fragilisBase SequenceBiologyCommunitiesComplement Factor BComplexDataDevelopmentDiseaseEquilibriumGastrointestinal tract structureGenomicsHealthHumanImmune systemInfectionInfectious AgentInflammatory disease of the intestineIntestinal DiseasesIntestinesInvestigationLibrariesLocationMaintenanceMammalsMediatingMicrobeMicrobiologyModelingMolecularOrganismPathway interactionsPolysaccharidesPopulationProbioticsReportingResearchSeminalSolidSurfaceSymbiosisVirulence FactorsWorkbasecommensal microbesenteric pathogenfightinggastrointestinalgenetic elementhuman diseaseimprovedmicrobial communitymicroorganismmutualismnovelpathogenpathogenic bacteriapreventpublic health relevancereceptor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Humans harbor a highly diverse and complex population of microorganisms in our gastrointestinal (GI) tracts that appear to have profound influences on the balance between health and disease. Although many recent investigations have focused on sequence-based profiling of microbial communities within the human gut, the mechanistic basis for how these communities are established and maintained is poorly described. We recently reported the first example of a molecular mechanism by which any symbiotic bacteria establishes initial colonization of a mammalian host. Our studies show that Bacteroides fragilis, a numerically prominent gut symbiont of humans, establishes colonization of the mammalian gut by varying its surface capsular polysaccharides (Liu, Lee et al., PNAS, 2008). This organism engenders health during its colonization of animals, as B. fragilis prevents intestinal inflammation caused by enteric pathogens. Therefore, B. fragilis augments our immune system to help fight diseases by infectious agents. Our preliminary data included, in this application, strongly suggest that maintenance of colonization is mediated by mechanisms distinct from initial colonization. Molecules other than capsular polysaccharides are required for stable association of B. fragilis with its host during protection from disease. As colonization of the GI tract by commensal bacteria helps our immune system fight infections, we propose to investigate the molecular mechanisms required during sustained host colonization by B. fragilis. Initially, we will characterize the anatomical niche occupied by B. fragilis within the intestines of experimental animals (Aim 1). Demonstration of a physical interaction between B. fragilis and its host will reinforce the hypothesis that this organism has evolved dedicated molecules that mediate gut colonization. Subsequently, we propose to identify and characterize the molecular machinery required for maintained intestinal colonization (Aim 2). The discovery of molecules that promote host-symbiont interactions will facilitate the development and delivery of novel probiotic therapies for human diseases caused by pathogenic bacteria.
PUBLIC HEALTH RELEVANCE: Decades of research in microbiology have identified numerous virulence factors from many diverse pathogens. However, the study of colonization factors employed by commensal bacteria has only recently been investigated. Bacteroides fragilis is an important commensal microorganism of the human gastrointestinal tract, and has emerged as a model symbiont due to its ability to prevent intestinal inflammation. Therefore, just as virulence factors are important for the biology of pathogens, colonization factors are important for symbiotic microbes to exert their profound benefits to their mammalian hosts. The discovery of molecules or molecular pathways that mediate host-symbiont association is a burgeoning and important area of research worthy of study.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Protection from Mucosal Pathology by Gut Microbiota during Experimental Colitis
-
批准号:10121503
-
项目类别:
-
资助金额:$41.6万
-
财政年份:2020
-
负责人:Sarkis K Mazmanian
-
依托单位:
Therapeutics for inflammatory bowel disease from the microbiome
-
批准号:8777885
-
项目类别:
-
资助金额:$39.68万
-
财政年份:2014
-
负责人:Sarkis K Mazmanian
-
依托单位:
Therapeutics for inflammatory bowel disease from the microbiome
-
批准号:9201532
-
项目类别:
-
资助金额:$197.34万
-
财政年份:2014
-
负责人:Sarkis K Mazmanian
-
依托单位:
The Gut Microbiome in Neurodegenerative Disease
-
批准号:8640692
-
项目类别:
-
资助金额:$33.3万
-
财政年份:2013
-
负责人:Sarkis K Mazmanian
-
依托单位:
Investigating the Gut Microbiome for Novel Therapies and Diagnostics for Autism
-
批准号:8850491
-
项目类别:
-
资助金额:$55.81万
-
财政年份:2013
-
负责人:Sarkis K Mazmanian
-
依托单位:
Investigating the Gut Microbiome for Novel Therapies and Diagnostics for Autism
-
批准号:9266505
-
项目类别:
-
资助金额:$55.81万
-
财政年份:2013
-
负责人:Sarkis K Mazmanian
-
依托单位:
The Gut Microbiome in Neurodegenerative Disease
-
批准号:8742025
-
项目类别:
-
资助金额:$32.97万
-
财政年份:2013
-
负责人:Sarkis K Mazmanian
-
依托单位:
Investigating the Gut Microbiome for Novel Therapies and Diagnostics for Autism
-
批准号:8484091
-
项目类别:
-
资助金额:$55.81万
-
财政年份:2013
-
负责人:Sarkis K Mazmanian
-
依托单位:
Investigating the Gut Microbiome for Novel Therapies and Diagnostics for Autism
-
批准号:8701411
-
项目类别:
-
资助金额:$55.81万
-
财政年份:2013
-
负责人:Sarkis K Mazmanian
-
依托单位:
The Gut Microbiome in Neurodegenerative Disease
-
批准号:9129767
-
项目类别:
-
资助金额:$33.3万
-
财政年份:2013
-
负责人:Sarkis K Mazmanian
-
依托单位:
Molecular Mechanisms that Shape Gut Microbial Communities
-
批准号:8415858
-
项目类别:
-
资助金额:$39.57万
-
财政年份:2012
-
负责人:Sarkis K Mazmanian
-
依托单位:
Molecular Mechanisms that Shape Gut Microbial Communities
-
批准号:8608548
-
项目类别:
-
资助金额:$41.0万
-
财政年份:2012
-
负责人:Sarkis K Mazmanian
-
依托单位:
Molecular Mechanisms that Shape Gut Microbial Communities
-
批准号:8798671
-
项目类别:
-
资助金额:$41.0万
-
财政年份:2012
-
负责人:Sarkis K Mazmanian
-
依托单位:
Molecular Mechanisms that Shape Gut Microbial Communities
-
批准号:8211978
-
项目类别:
-
资助金额:$41.0万
-
财政年份:2012
-
负责人:Sarkis K Mazmanian
-
依托单位:
Probiotic therapies for food allergies
-
批准号:8141362
-
项目类别:
-
资助金额:$16.04万
-
财政年份:2010
-
负责人:Sarkis K Mazmanian
-
依托单位:
Identification of Bacteroides Fragilis Colonization during Host Mutualism
-
批准号:8059609
-
项目类别:
-
资助金额:$16.04万
-
财政年份:2010
-
负责人:Sarkis K Mazmanian
-
依托单位:
Probiotic therapies for food allergies
-
批准号:7895426
-
项目类别:
-
资助金额:$28.35万
-
财政年份:2010
-
负责人:Sarkis K Mazmanian
-
依托单位:
Protection from Mucosal Pathology by Gut Microflora during Experimental Colitis
-
批准号:8245742
-
项目类别:
-
资助金额:$34.53万
-
财政年份:2009
-
负责人:Sarkis K Mazmanian
-
依托单位:
Protection from Mucosal Pathology by Gut Microbiota during Colitis
-
批准号:8735933
-
项目类别:
-
资助金额:$25.76万
-
财政年份:2009
-
负责人:Sarkis K Mazmanian
-
依托单位:
Protection from Mucosal Pathology by Gut Microflora during Experimental Colitis
-
批准号:7655741
-
项目类别:
-
资助金额:$38.7万
-
财政年份:2009
-
负责人:Sarkis K Mazmanian
-
依托单位:
海外基金